Intelligence Platform

Patents

Browse 783 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

US 9758761

Aligned and electrospun piezoelectric polymer fiber assembly and scaffold

The United States of America as represented by the Administrator of the National Aeronautics and Space Administration · Granted Tue Sep 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9724376

Olive leaf powder

The United States of America as Represented by the Secretary of the Department of Agriculture · Granted Tue Aug 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9700578

Use of nitrite salts for the treatment of cardiovascular conditions

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9687542

Rift valley fever virus replicon particles and use thereof

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Tue Jun 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9683024

Recombinantly expressed plasmodium CelTOS antigen and methods of use thereof

The United States of America as represented by the Secretary of the Army · Granted Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9682107

Postnatal stem cells and uses thereof

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9682088

Method for treating uterine fibroids

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9675637

Use of nitrite salts for the treatment of cardiovascular conditions

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9675684

Gene optimized hantaan virus M segment DNA vaccine for hemorrhagic fever with renal syndro

The United States of America as represented by the Secretary of the Army · Granted Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9676858

Human bispecific EGFRvIII antibody and CD3 engaging molecules

The United States of America as Represented by the Secretary Department of Health and Human Services (NIH) · Granted Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9675572

Intravenous omega-3 fatty acid compositions and method of use

The United States of America as represented by the Secretary of the Army · Granted Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9651462

Method and system for sampling and separating submicron-sized particles based on density a

The United States of America as represented by the Secretary of the Army · Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9650422

Localization and characterization of flavivirus envelope glycoprotein cross-reactive epito

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9629816

Small molecule therapeutic compounds targeting thioesterase deficiency disorders and metho

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9623097

Yeast-brachyury immunotherapeutic compositions

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9617526

Mutated organophosphorus acid anhydrolases and their uses thereof

The United States of America as represented by the Secretary of the Army · Granted Tue Apr 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9598492

Human monoclonal antibodies specific for CD22

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Mar 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9598441

Therapeutic compounds and methods

The United States of America as represented by the Department of Veteran Affairs · Granted Tue Mar 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9592304

Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Mar 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9587232

Mutated organophosphorus acid anhydrolases and their uses thereof

The United States of America as represented by the Secretary of the Army · Granted Tue Mar 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9567566

HMGN polypeptides as immune enhancers and HMGN antagonists as immune suppressants

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Feb 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9555064

Protease-deficient Bacillus anthracis

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9546151

VMAT inhibitory compounds

The United States of America as represented by the Department of Veteran Affairs · Granted Tue Jan 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9533031

Yeast-MUC1 immunotherapeutic compositions and uses thereof

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)